NCT07211321 Linking Diet, Inflammation, Gut Microbiota, and Sarcopenia: A Cross-Sectional Study
| NCT ID | NCT07211321 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jianhua Ma |
| Condition | Sarcopenia |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,220 participants |
| Start Date | 2024-04-16 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,220 participants in total. It began in 2024-04-16 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Based on the analysis of dietary characteristics, gut microbiota diversity, and composition, this study investigates the relationships between the dietary inflammatory potential, gut microbiota, and sarcopenia. Furthermore, it explores the mediating role of gut microbiota in the association between the dietary inflammatory index and the risk of sarcopenia. The findings are expected to provide insights into the mechanisms through which dietary inflammation influences the development and progression of sarcopenia, and to offer a basis for dietary and nutritional interventions aimed at preventing or managing this condition.
Eligibility Criteria
Inclusion Criteria: * Permanent residents of the community aged 60 years or older. * Continuous residence duration in the community for more than 5 years. Exclusion Criteria: * Taking medications known to affect muscle function (e.g., corticosteroids, protein supplements, muscle enhancers). * Requiring walking assistance or having severe cognitive impairment that would preclude successful completion of assessments including bioelectrical impedance analysis (BIA), gait speed measurement, and handgrip strength testing. * Presence of a cardiac pacemaker, which contraindicates BIA measurement. * Diagnosis of one or more chronic diseases that significantly limit dietary intake.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07211321 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Sarcopenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07211321 currently recruiting?
Yes, NCT07211321 is actively recruiting participants. Contact the research team at majianhua@lzu.edu.cn for enrollment information.
Where is the NCT07211321 trial being conducted?
This trial is being conducted at Lanzhou, China.
Who is sponsoring the NCT07211321 clinical trial?
NCT07211321 is sponsored by Jianhua Ma. The trial plans to enroll 1,220 participants.